|
(Health-NewsWire.Net, April 30, 2015 ) Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Complete report on 2015 Product pipeline review of “Agile Therapeutics, Inc.” addiction with 15 market data tables and 6 figures, spread across 28 pages is available at http://www.rnrmarketresearch.com/agile-therapeutics-inc-product-pipeline-review-2015-market-report.html . (This is a premium report price at US$1500 for a single user PDF license)
This report provides comprehensive information on the current therapeutic developmental pipeline of Agile Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Scope:
• The report provides brief overview of Agile Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
• The report reviews current pipeline of Agile Therapeutics, Inc.’s human therapeutic division and enlists all their major and minor projects
• The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
• Special feature on out-licensed and partnered product portfolio
• The report summarizes all the dormant and discontinued pipeline projects
• Latest news and deals relating to the Agile Therapeutics, Inc.’s pipeline products
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Inquire for discount on this report at http://www.rnrmarketresearch.com/contacts/discount?rname=375179 .
Reasons to Buy:
• Evaluate Agile Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline
• Assess the growth potential of Agile Therapeutics, Inc. in its therapy areas of focus
• Identify new drug targets and therapeutic classes in the Agile Therapeutics, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
• Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
• Develop strategic initiatives by understanding the focus areas of Agile Therapeutics, Inc. and exploit collaboration and partnership opportunities
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by identifying the most promising pipeline of Agile Therapeutics, Inc.
More reports on Therapeutics :
2015 Market Research Report on Global and China Meropenem Industry
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Meropenem market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Meropenem industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided.
Complete report is available at http://www.rnrmarketresearch.com/2015-market-research-report-on-global-and-china-meropenem-industry-market-report.html .
RnR Market Research
Ritesh Tiwari
+ 1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
|
